# Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

> **NCT03321539** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 216 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** CCRT+GP
- **DRUG:** CCRT+PF

## Key facts

- **NCT ID:** NCT03321539
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-30
- **Primary completion:** 2022-12-25
- **Final completion:** 2025-12-31
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321539, "Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03321539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*